Globalworld globe
United Kingdom
North America
  • facebook
  • linkedin
Medical Developments International
  • Home
  • Products
    • Asthma & COPD
    • Penthrox
    • Medical Devices
    • Veterinary
  • About
    • Distributor Information
    • Careers
    • Associations
  • Investors/Media
    • Financial Reports
    • Board of Directors/Management
    • Corporate Governance
    • Media Centre
    • Diversity Policy
    • Share Trading Policy
  • Healthcare Professionals
  • Contact

News

First Penthrox order received for Austria

Feb 18, 2018Mark EdwardsNews

19 February 2018

ASX Announcement

Penthrox : First order received for Austria

Medical Developments International Limited (ASX: MVP) is delighted to announce that it has received its first order for Penthrox for launch in Austria. The Marketing Authorisation for Austria was received and announced on 29 January 2018.

The company is expecting other orders to be received in the coming months as Marketing Authorisations are received from other countries.

For the full ASX announcement, please refer to the following link – ASX Announcement – First Penthrox order for Austria

 

Contact Us

for information on our range of products

Find a distributor

in our global network

Investors

invest in a company with
innovative foresight

News

  • Trading and Market Update

    30 October 2018 ASX Annou...

  • Chairman’s and CEO’s Address to Shareholders

    Please refer to the follo...

  • Penthrox is approved in Saudi Arabia

    11 October 2018 ASX Annou...

Healthcare Professional Registration

Login to access healthcare professional resources


Remember Me

Forgot password? | Register

Medical Developments International

Address: 4 Caribbean Drive, Scoresby,
Victoria, 3179
Australia
Phone: +61 3 9547 1888
Email: mdi@medicaldev.com
ABN: 14 106 340 667
For Medical Enquiries:
Phone: 1800 PENTHROX (1800 736 847)
Email: medinf@medicaldev.com

Email Newsletter

Sign up to our newsletter to receive MDI corporate, investor  & media news.